HEADACHE/MIGRAINE RESEARCH

Actively Enrolling Studies

Currently Enrolling Studies

APT Comparison (25-1138)

Investigator: Nicole Caunt, DO
Purpose: to compare the effectiveness of a newer oral migraine preventative (atogepant) to two older, commonly used medications (propranolol and topiramate) for migraine prevention
Intervention: participants will be randomly assigned to one of the three medications
Timeline: 4 week screening period, 12 week study treatment period, and optional long-term follow-up period for 36 weeks
ClinicalTrials.gov Identifier: NCT06972056
Key Eligibility Criteria:
- Ages 18-70 years
- At least 4 moderate to severe headache days per month
- Has not previously taken atogepant, propranolol, or topiramate
- Not currently taking any CGRP-targeting preventative medications

Get Connected

If you think you may be eligible for one of these studies or if you would like more information, please fill out our Neurology Research Interest Web Form or contact us at N [email protected] or 303-724-4644.

Principal Investigators

Marcus Birlea, MD

Danielle Wilhour, MD

Local Neurology Events

No events currently scheduled.

Further Resources

American Migraine Foundation

The American Migraine Foundation (AMF) is a non-profit organization dedicated to the advancement of research and awareness surrounding migraine, a disabling condition that impacts more than 39 million men, women and children in the United States.

National Headache Foundation

In support of our mission, the National Headache Foundation looks to achieve these key goals: awareness, advocacy, education and research. Vision statement: a world without headache.

Neurology

CU Anschutz

Research Complex II

12700 East 19th Avenue

5018

Aurora, CO 80045

303-724-4328

Facebook Twitter

Tools & Resources

CU Campuses

CU Anschutz

Department of Neurology

School of Medicine

HEADACHE/MIGRAINE RESEARCH

Actively Enrolling Studies